Lotte Biologics Co., Ltd announced a private placement of 3,700,000 common shares of KRW 65,000 each for the gross proceeds of KRW 240.5 billion on October 20, 2022. The transaction has been approved by shareholders of the company. Discount rate or premium rate (%) compared to par value per share is KRW 1,200.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27,050 KRW | +2.08% | +6.50% | 0.00% |
07:57am | Lotte Group Agrees to Divest Theme Park Project in China for KRW450 Billion | MT |
Apr. 25 | South Korea's Lotte sells China theme park project for $326 mln, reports MoneyToday | RE |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.41B | |
+20.05% | 11.58B | |
-29.23% | 8.33B | |
+12.02% | 6.21B | |
-17.07% | 5.54B | |
+4.90% | 4.24B | |
+3.00% | 2.79B | |
-20.78% | 2.72B | |
-35.65% | 1.97B | |
+0.28% | 1.67B |
- Stock Market
- Equities
- A004990 Stock
- News LOTTE Corporation
- Lotte Biologics Co., Ltd announced that it expects to receive KRW 240.5 billion in funding from LOTTE Corporation